These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27234564)

  • 1. Role of nucleotide excision repair proteins in response to DNA damage induced by topoisomerase II inhibitors.
    Rocha JC; Busatto FF; Guecheva TN; Saffi J
    Mutat Res Rev Mutat Res; 2016; 768():68-77. PubMed ID: 27234564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential and common DNA repair pathways for topoisomerase I- and II-targeted drugs in a genetic DT40 repair cell screen panel.
    Maede Y; Shimizu H; Fukushima T; Kogame T; Nakamura T; Miki T; Takeda S; Pommier Y; Murai J
    Mol Cancer Ther; 2014 Jan; 13(1):214-20. PubMed ID: 24130054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanidine-reactive agent phenylglyoxal induces DNA damage and cancer cell death.
    Calderón-Montaño JM; Burgos-Morón E; Orta ML; Pastor N; Perez-Guerrero C; Austin CA; Mateos S; López-Lázaro M
    Pharmacol Rep; 2012; 64(6):1515-25. PubMed ID: 23406762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms to Repair Stalled Topoisomerase II-DNA Covalent Complexes.
    Swan RL; Cowell IG; Austin CA
    Mol Pharmacol; 2022 Jan; 101(1):24-32. PubMed ID: 34689119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA repair in response to anthracycline-DNA adducts: a role for both homologous recombination and nucleotide excision repair.
    Spencer DM; Bilardi RA; Koch TH; Post GC; Nafie JW; Kimura K; Cutts SM; Phillips DR
    Mutat Res; 2008 Feb; 638(1-2):110-21. PubMed ID: 17961607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic evidence for involvement of two distinct nonhomologous end-joining pathways in repair of topoisomerase II-mediated DNA damage.
    Adachi N; Iiizumi S; So S; Koyama H
    Biochem Biophys Res Commun; 2004 Jun; 318(4):856-61. PubMed ID: 15147950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA repair functions that control sensitivity to topoisomerase-targeting drugs.
    Malik M; Nitiss JL
    Eukaryot Cell; 2004 Feb; 3(1):82-90. PubMed ID: 14871939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly of nuclear matrix-bound protein complexes involved in non-homologous end joining is induced by inhibition of DNA topoisomerase II.
    Kantidze OL; Iarovaia OV; Razin SV
    J Cell Physiol; 2006 Jun; 207(3):660-7. PubMed ID: 16447266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topoisomerase deficiencies subtly enhance global genomic repair of ultraviolet-induced DNA damage in Saccharomyces cerevisiae.
    Cline SD; Hanawalt PC
    DNA Repair (Amst); 2006 May; 5(5):611-7. PubMed ID: 16516562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
    Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
    Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells exhibit resistance to topoisomerase inhibition.
    Nicolay NH; Rühle A; Perez RL; Trinh T; Sisombath S; Weber KJ; Schmezer P; Ho AD; Debus J; Saffrich R; Huber PE
    Cancer Lett; 2016 Apr; 374(1):75-84. PubMed ID: 26876302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing of anthracycline-DNA adducts via DNA replication and interstrand crosslink repair pathways.
    Bilardi RA; Kimura KI; Phillips DR; Cutts SM
    Biochem Pharmacol; 2012 May; 83(9):1241-50. PubMed ID: 22326903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DNA repair player, ring finger protein 43, relieves etoposide-induced topoisomerase II poisoning.
    Lerksuthirat T; Wikiniyadhanee R; Stitchantrakul W; Chitphuk S; Stansook N; Pipatpanyanugoon N; Jirawatnotai S; Dejsuphong D
    Genes Cells; 2020 Nov; 25(11):718-729. PubMed ID: 32939879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy.
    Xu Y; Her C
    Biomolecules; 2015 Jul; 5(3):1652-70. PubMed ID: 26287259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycle-dependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells.
    Frankenberg-Schwager M; Becker M; Garg I; Pralle E; Wolf H; Frankenberg D
    Radiat Res; 2008 Dec; 170(6):784-93. PubMed ID: 19138034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a role of vertebrate Rad52 in the repair of topoisomerase II-mediated DNA damage.
    Adachi N; Iiizumi S; Koyama H
    DNA Cell Biol; 2005 Jun; 24(6):388-93. PubMed ID: 15941391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair and chromosomal alterations.
    Natarajan AT; Palitti F
    Mutat Res; 2008 Nov; 657(1):3-7. PubMed ID: 18801460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-Damaging Anticancer Drugs - A Perspective for DNA Repair- Oriented Therapy.
    Blasiak J
    Curr Med Chem; 2017; 24(15):1488-1503. PubMed ID: 28120709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks.
    Sabourin M; Nitiss JL; Nitiss KC; Tatebayashi K; Ikeda H; Osheroff N
    Nucleic Acids Res; 2003 Aug; 31(15):4373-84. PubMed ID: 12888496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
    Jacob S; Aguado M; Fallik D; Praz F
    Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.